Reduction of serum hepcidin by hemodialysis in pediatric and adult patients.
Zaritsky
Joshua
J
Department of Pediatrics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA. jzaritsky@mednet.ucla.edu
Young
Brian
B
Gales
Barbara
B
Wang
He-Jing
HJ
Rastogi
Anjay
A
Westerman
Mark
M
Nemeth
Elizabeta
E
Ganz
Tomas
T
Salusky
Isidro B
IB
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D023181:Antimicrobial Cationic Peptides / Q000097:blood*; D015415:Biomarkers / Q000097:blood; D002097:C-Reactive Protein / Q000378:metabolism; D002648:Child; D015536:Down-Regulation; D004797:Enzyme-Linked Immunosorbent Assay; D004920:Erythropoiesis / Q000187:drug effects; D005260:Female; D005293:Ferritins / Q000097:blood; D006397:Hematinics / Q000627:therapeutic use; D064451:Hepcidins; D006801:Humans; D018836:Inflammation Mediators / Q000097:blood*; D007501:Iron / Q000097:blood; D007700:Kinetics; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis; D016896:Treatment Outcome; D055815:Young Adult
D023181:Antimicrobial Cationic Peptides; D015415:Biomarkers; C578702:HAMP protein, human; D006397:Hematinics; D064451:Hepcidins; D018836:Inflammation Mediators; D002097:C-Reactive Protein; D005293:Ferritins; D007501:Iron